Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

NU SKIN ENTERPRISES, INC.

NUS Clue Score52
United States Fiscal year ends December CIK 0001021561 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Steven Keith Hatchett
11 Nov 2025
Chief Product Officer
Buy
5,500
$9.61
$52.86K
Steven Keith Hatchett
28 May 2025
Chief Product Officer
Buy
6,500
$7.54
$49.01K
Daniel W Campbell
18 Feb 2021
Director
Buy indirect
5,055
$49.48
$250.12K
Daniel W Campbell
18 Feb 2021
Director
Buy
5,055
$49.49
$250.17K
Steven Lund
17 Feb 2021
Exec. Chairman of the Board
Buy indirect
20,850
$48.05
$1.00M
Daniel W Campbell
17 Feb 2021
Director
Buy indirect
4,955
$50.69
$251.17K
Daniel W Campbell
17 Feb 2021
Director
Buy
4,955
$50.60
$250.72K
Ritch N Wood
20 Mar 2020
Chief Executive Officer
Buy
10,000
$20.25
$202.50K

What was left out

Form 4 filings counted 444
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 106
Sales at will 90
Transactions with no price 0
Shares from compensation/vesting 6,761,036
Sales filed before the plan box existed 66
History held since 2 Nov 2006